Effect of highly specific inhibitors of oxidative phosphorylation, dicyclohexylcarbodiimide, antimycin A and piercidin A, on cyclic AMP accumulation induced by noradrenaline and theophylline in rat adipose tissue.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000418:Albumins / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D000968:Antimycin A / Q000494:pharmacology*; D002234:Carbodiimides / Q000494:pharmacology*; D000242:Cyclic AMP / Q000302:isolation & purification / Q000378:metabolism*; D003864:Depression, Chemical; D004024:Dicyclohexylcarbodiimide; D004357:Drug Synergism; D004822:Epididymis / Q000378:metabolism; D066298:In Vitro Techniques; D050356:Lipid Metabolism; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology*; D010085:Oxidative Phosphorylation / Q000187:drug effects*; D010759:Phosphorus Isotopes; D011725:Pyridines / Q000494:pharmacology*; D051381:Rats; D013806:Theophylline / Q000494:pharmacology*
D000418:Albumins; D000900:Anti-Bacterial Agents; D002234:Carbodiimides; D010759:Phosphorus Isotopes; D011725:Pyridines; D004024:Dicyclohexylcarbodiimide; D000968:Antimycin A; D013806:Theophylline; D000242:Cyclic AMP; D009638:Norepinephrine